Concepedia

S.A. Hurvitz

SH

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2025

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

S.A. Hurvitz is an author at The University of Texas MD Anderson Cancer Center specializing in breast cancer chemotherapy, checkpoint inhibitor therapy, and her2-positive breast cancer therapy.

Publications per year

2025–2025

1

Publications

1

LBA17 Gedatolisib (geda) + fulvestrant ± palbociclib (palbo) vs fulvestrant in patients (pts) with HR+/ HER2-/PIK3CA wild-type (WT) advanced breast cancer (ABC): First results from VIKTORIA-1

S.A. Hurvitz, R.M. Layman, G. Curigliano et al. · Annals of Oncology · 2025 · 10 citations · Full text

, , +15

1–1 of 1